Literature DB >> 29700116

Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Nicolas Giguère1,2, Consiglia Pacelli3, Caroline Saumure1,2, Marie-Josée Bourque1,2, Diana Matheoud2,4, Daniel Levesque5,5, Ruth S Slack6, David S Park6, Louis-Éric Trudeau7,2,5,8.   

Abstract

Many mutations in genes encoding proteins such as Parkin, PTEN-induced putative kinase 1 (PINK1), protein deglycase DJ-1 (DJ-1 or PARK7), leucine-rich repeat kinase 2 (LRRK2), and α-synuclein have been linked to familial forms of Parkinson's disease (PD). The consequences of these mutations, such as altered mitochondrial function and pathological protein aggregation, are starting to be better understood. However, little is known about the mechanisms explaining why alterations in such diverse cellular processes lead to the selective loss of dopamine (DA) neurons in the substantia nigra (SNc) in the brain of individuals with PD. Recent work has shown that one of the reasons for the high vulnerability of SNc DA neurons is their high basal rate of mitochondrial oxidative phosphorylation (OXPHOS), resulting from their highly complex axonal arborization. Here, we examined whether axonal growth and basal mitochondrial function are altered in SNc DA neurons from Parkin-, Pink1-, or DJ-1-KO mice. We provide evidence for increased basal OXPHOS in Parkin-KO DA neurons and for reduced survival of DA neurons that have a complex axonal arbor. The surviving smaller neurons exhibited reduced vulnerability to the DA neurotoxin and mitochondrial complex I inhibitor MPP+, and this reduction was associated with reduced expression of the DA transporter. Finally, we found that glial cells play a role in the reduced resilience of DA neurons in these mice and that WT Parkin overexpression rescues this phenotype. Our results provide critical insights into the complex relationship between mitochondrial function, axonal growth, and genetic risk factors for PD.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  PTEN-induced putative kinase 1 (PINK1); Parkinson disease; axon; bioenergetics; cell culture; dopamine; mitochondria; parkin

Mesh:

Substances:

Year:  2018        PMID: 29700116      PMCID: PMC6016451          DOI: 10.1074/jbc.RA117.000499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

Authors:  M Emdadul Haque; Kelly J Thomas; Cheryl D'Souza; Steve Callaghan; Tohru Kitada; Ruth S Slack; Paul Fraser; Mark R Cookson; Anurag Tandon; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-24       Impact factor: 11.205

2.  Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons.

Authors:  Yong Ren; Houbo Jiang; Zhixing Hu; Kevin Fan; Jun Wang; Stephen Janoschka; Xiaomin Wang; Shaoyu Ge; Jian Feng
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

3.  GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons.

Authors:  K Nakajima; H Hida; Y Shimano; I Fujimoto; T Hashitani; M Kumazaki; T Sakurai; H Nishino
Journal:  Brain Res       Date:  2001-10-19       Impact factor: 3.252

4.  PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.

Authors:  Masatoshi Inden; Takahiro Taira; Yoshihisa Kitamura; Takashi Yanagida; Daiju Tsuchiya; Kazuyuki Takata; Daijiro Yanagisawa; Kaneyasu Nishimura; Takashi Taniguchi; Yoshiaki Kiso; Kanji Yoshimoto; Tomohiro Agatsuma; Shizuyo Koide-Yoshida; Sanae M M Iguchi-Ariga; Shun Shimohama; Hiroyoshi Ariga
Journal:  Neurobiol Dis       Date:  2006-07-24       Impact factor: 5.996

Review 5.  Mitochondrial biology and Parkinson's disease.

Authors:  Celine Perier; Miquel Vila
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

6.  Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.

Authors:  Daniel A Stevens; Yunjong Lee; Ho Chul Kang; Byoung Dae Lee; Yun-Il Lee; Aaron Bower; Haisong Jiang; Sung-Ung Kang; Shaida A Andrabi; Valina L Dawson; Joo-Ho Shin; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 7.  Candidate genes for Parkinson disease: Lessons from pathogenesis.

Authors:  Priscilla De Rosa; Elettra Sara Marini; Vania Gelmetti; Enza Maria Valente
Journal:  Clin Chim Acta       Date:  2015-06-03       Impact factor: 3.786

8.  Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease.

Authors:  Zhi Yao; Sonia Gandhi; Victoria S Burchell; Helene Plun-Favreau; Nicholas W Wood; Andrey Y Abramov
Journal:  J Cell Sci       Date:  2012-01-05       Impact factor: 5.285

9.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

10.  Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.

Authors:  Francisco A Perez; Wendy R Curtis; Richard D Palmiter
Journal:  BMC Neurosci       Date:  2005-12-24       Impact factor: 3.288

View more
  17 in total

Review 1.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Maria Nguyen; Yvette C Wong; Daniel Ysselstein; Alex Severino; Dimitri Krainc
Journal:  Trends Neurosci       Date:  2018-11-30       Impact factor: 13.837

Review 2.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

3.  Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line.

Authors:  Rong-Tzong Tsai; Chia-Wen Tsai; Shih-Ping Liu; Jia-Xin Gao; Yun-Hua Kuo; Pei-Min Chao; Huey-Shan Hung; Woei-Cherng Shyu; Shinn-Zong Lin; Ru-Huei Fu
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

4.  Increased Levels of cAMP by the Calcium-Dependent Activation of Soluble Adenylyl Cyclase in Parkin-Mutant Fibroblasts.

Authors:  Paola Tanzarella; Anna Ferretta; Simona Nicol Barile; Mariella Ancona; Domenico De Rasmo; Anna Signorile; Sergio Papa; Nazzareno Capitanio; Consiglia Pacelli; Tiziana Cocco
Journal:  Cells       Date:  2019-03-15       Impact factor: 6.600

5.  Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism.

Authors:  Consiglia Pacelli; Giovannina Rotundo; Lucia Lecce; Marta Menga; Eris Bidollari; Rosella Scrima; Olga Cela; Claudia Piccoli; Tiziana Cocco; Angelo Luigi Vescovi; Gianluigi Mazzoccoli; Jessica Rosati; Nazzareno Capitanio
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

6.  The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes.

Authors:  Miriam Ciani; Cristian Bonvicini; Catia Scassellati; Matteo Carrara; Carlo Maj; Silvia Fostinelli; Giuliano Binetti; Roberta Ghidoni; Luisa Benussi
Journal:  Int J Mol Sci       Date:  2019-08-10       Impact factor: 5.923

7.  Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-α-Synuclein Mouse Model of Parkinson's Disease.

Authors:  Huiying Li; Hongquan Wang; Ling Zhang; Manshi Wang; Yanfeng Li
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

8.  MCL-1Matrix maintains neuronal survival by enhancing mitochondrial integrity and bioenergetic capacity under stress conditions.

Authors:  Ujval Anilkumar; Mireille Khacho; Alexanne Cuillerier; Richard Harris; David A Patten; Maria Bilen; Mohamed Ariff Iqbal; Ding Yuan Guo; Louis-Eric Trudeau; David S Park; Mary-Ellen Harper; Yan Burelle; Ruth S Slack
Journal:  Cell Death Dis       Date:  2020-05-05       Impact factor: 8.469

9.  LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia.

Authors:  Judong Kim; Edward Pajarillo; Asha Rizor; Deok-Soo Son; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

10.  Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.

Authors:  Saeideh Momtaz; Zahra Memariani; Fardous F El-Senduny; Nima Sanadgol; Fereshteh Golab; Majid Katebi; Amir Hossein Abdolghaffari; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Front Physiol       Date:  2020-04-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.